Your browser doesn't support javascript.
loading
Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.
Wang, Gangyang; Sun, Mengxiong; Jiang, Yafei; Zhang, Tao; Sun, Wei; Wang, Hongsheng; Yin, Fei; Wang, Zhuoying; Sang, Weilin; Xu, Jing; Mao, Min; Zuo, Dongqing; Zhou, Zifei; Wang, Chongren; Fu, Zeze; Wang, Zongyi; Duan, Zhenfeng; Hua, Yingqi; Cai, Zhengdong.
Afiliação
  • Wang G; Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Sun M; Shanghai Bone Tumor Institute, Shanghai, China.
  • Jiang Y; Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang T; Shanghai Bone Tumor Institute, Shanghai, China.
  • Sun W; Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang H; Shanghai Bone Tumor Institute, Shanghai, China.
  • Yin F; Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang Z; Shanghai Bone Tumor Institute, Shanghai, China.
  • Sang W; Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xu J; Shanghai Bone Tumor Institute, Shanghai, China.
  • Mao M; Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zuo D; Shanghai Bone Tumor Institute, Shanghai, China.
  • Zhou Z; Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang C; Shanghai Bone Tumor Institute, Shanghai, China.
  • Fu Z; Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang Z; Shanghai Bone Tumor Institute, Shanghai, China.
  • Duan Z; Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Hua Y; Shanghai Bone Tumor Institute, Shanghai, China.
  • Cai Z; Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Int J Cancer ; 145(4): 979-993, 2019 08 15.
Article em En | MEDLINE | ID: mdl-30719715
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias Ósseas / Osteossarcoma / Proteínas Proto-Oncogênicas c-met / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Inibidores de Proteínas Quinases / Indóis Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias Ósseas / Osteossarcoma / Proteínas Proto-Oncogênicas c-met / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Inibidores de Proteínas Quinases / Indóis Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China